{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:16:47Z","timestamp":1762460207288,"version":"3.38.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT02221102"],"award-info":[{"award-number":["NCT02221102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jns.2024.123231","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:09:42Z","timestamp":1726135782000},"page":"123231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Heart failure and stroke: The underrepresentation of the heart failure with preserved ejection fraction subtype in randomized clinical trials of therapeutic anticoagulation"],"prefix":"10.1016","volume":"466","author":[{"given":"Odysseas","family":"Kargiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Safouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klearchos","family":"Psychogios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Saposnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Yaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123231_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0010","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/ejhf.3003","article-title":"Sex differences in long-term outcomes following acute heart failure hospitalization: findings from the get with the guidelines-heart failure registry","volume":"2","author":"Keshvani","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ejhf.3115","article-title":"Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction","volume":"26","author":"Wu","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hfc.2018.12.004","article-title":"The role of echocardiography in heart failure with preserved ejection fraction: what do we want from imaging?","volume":"15","author":"Obokata","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.jns.2024.123231_bb0025","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0030","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCULATIONAHA.122.063642","article-title":"Clinical characteristics and outcomes in patients with heart failure: are there thresholds and inflection points in left ventricular ejection fraction and thresholds justifying a clinical classification?","volume":"148","author":"Kondo","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123231_bb0040","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/ehf2.14685","article-title":"Heart failure outcomes by left ventricular ejection fraction in a contemporary region-wide patient cohort","volume":"11","author":"Sundstr\u00f6m","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/jcm10051146","article-title":"Ischemic stroke and heart failure: facts and numbers. An update","volume":"10","author":"Barkhudaryan","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2024.123231_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardfail.2008.09.001","article-title":"Nationwide frequency and association of heart failure on stroke outcomes in the United States","volume":"15","author":"Divani","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00415-008-0677-1","article-title":"Heart failure in acute ischemic stroke","volume":"255","author":"Ois","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123231_bb0060","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.STR.0000227121.34717.40","article-title":"Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population","volume":"37","author":"Hays","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ejhf.1100","article-title":"Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the study group on heart and brain interaction of the heart failure association","volume":"20","author":"Doehner","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0070","first-page":"1424","article-title":"Does heart failure confer a hypercoagulable state? Virchow\u2019s triad revisited","volume":"33","author":"Lip","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2024.123231_bb0075","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2024.123231_bb0080","first-page":"119","article-title":"Endothelial dysfunction in heart failure","volume":"60","author":"Bauersachs","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jns.2024.123231_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/14.2.205","article-title":"Platelet function, thrombin and fibrinolytic activity in patients with heart failure","volume":"14","author":"Jafri","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jns.2024.123231_bb0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1536\/ihj.50.591","article-title":"Procoagulant state in heart failure with preserved left ventricular ejection fraction","volume":"50","author":"Jug","year":"2009","journal-title":"Int. Heart J."},{"key":"10.1016\/j.jns.2024.123231_bb0095","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1161\/STROKEAHA.111.628479","article-title":"Chronic heart failure and ischemic stroke","volume":"42","author":"Haeusler","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0100","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.jacc.2020.10.009","article-title":"Post-stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review","volume":"76","author":"Sposato","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2024.123231_bb0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1474-4422(18)30336-3","article-title":"Stroke-heart syndrome: clinical presentation and underlying mechanisms","volume":"17","author":"Scheitz","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123231_bb0110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2147\/CLEP.S261179","article-title":"Long-term risk of stroke and poststroke outcomes in patients with heart failure: two nationwide studies","volume":"12","author":"Tai","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.jns.2024.123231_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ehf2.12026","article-title":"Ischemic stroke and heart failure: facts and numbers","volume":"2","author":"Scherbakov","year":"2015","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jns.2024.123231_bb0120","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/STROKEAHA.116.016022","article-title":"Risk of stroke in patients with heart failure: a population-based 30-year cohort study","volume":"48","author":"Adelborg","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00380-017-1073-5","article-title":"Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)","volume":"33","author":"Sobue","year":"2018","journal-title":"Heart Vessel."},{"key":"10.1016\/j.jns.2024.123231_bb0130","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.114.013760","volume":"131","author":"Abdul-Rahim","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123231_bb0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijcard.2009.04.035","article-title":"Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: findings from the DIG stroke sub-study","volume":"144","author":"Mujib","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2024.123231_bb0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jns.2016.01.053","article-title":"Heart failure and the risk of ischemic stroke recurrence: a systematic review and meta-analysis","volume":"362","author":"Katsanos","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123231_bb0145","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.013","article-title":"Stroke and heart failure: clinical features, access to care, and outcomes","volume":"25","author":"Pongmoragot","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2024.123231_bb0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.112.000143","article-title":"Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"6","author":"McMurray","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The warfarin\/aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"14","author":"Cleland","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jns.2024.123231_bb0165","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123231_bb0170","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.123231_bb0175","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.123231_bb0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.119.039609","article-title":"Rivaroxaban with or without aspirin in patients with heart failure and chronic coronary or peripheral artery disease","volume":"140","author":"Branch","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123231_bb0185","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2021.3828","article-title":"Left ventricular dysfunction among patients with embolic stroke of undetermined source and the effect of rivaroxaban vs aspirin: a subgroup analysis of the NAVIGATE ESUS randomized clinical trial","volume":"78","author":"Merkler","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123231_bb0190","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","volume":"5","author":"Shantsila","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2024.123231_bb0195","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1161\/STROKEAHA.120.033910","article-title":"Association of oral anticoagulation with stroke in atrial fibrillation or heart failure: a comparative meta-analysis","volume":"52","author":"Reddin","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0200","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/STROKEAHA.121.036706","article-title":"Acute ischemic stroke, depressed left ventricular ejection fraction, and sinus rhythm: prevalence and practice patterns","volume":"53","author":"Baker","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0205","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/ejhf.1946","article-title":"What should the C (\u2019congestive heart failure\u2019) represent in the CHA2 DS2 -VASc score?","volume":"22","author":"Mulder","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/STROKEAHA.114.007140","article-title":"Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure","volume":"46","author":"Sandhu","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123231_bb0215","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a Meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jns.2024.123231_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjcard.2023.07.058","article-title":"Atrial myopathy and ischemic stroke in heart failure with preserved ejection fraction","volume":"203","author":"Farhat","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jns.2024.123231_bb0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jcmg.2014.01.016","article-title":"Association of CMR-measured LA function with heart failure development: results from the MESA study","volume":"7","author":"Habibi","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jns.2024.123231_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11897-021-00510-5","article-title":"Left atrial myopathy in atrial fibrillation and heart failure: clinical implications, mechanisms, and therapeutic targets","volume":"18","author":"Peigh","year":"2021","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.jns.2024.123231_bb0235","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial Cardiopathy: the ARCADIA randomized clinical trial","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2024.123231_bb0240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jama.2023.23916","article-title":"Anticoagulation for atrial Cardiopathy in cryptogenic stroke","volume":"331","author":"Marcus","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2024.123231_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"Authors\/Task Force Members","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jns.2024.123231_bb0250","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/ejhf.3071","article-title":"Interaction of heart failure and stroke: a clinical consensus statement of the ESC Council on stroke, the heart failure association (HFA) and the ESC working group on thrombosis","volume":"25","author":"Doehner","year":"2023","journal-title":"Eur. J. Heart Fail."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:05:50Z","timestamp":1741064750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"alternative-id":["S0022510X24003666"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123231","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure and stroke: The underrepresentation of the heart failure with preserved ejection fraction subtype in randomized clinical trials of therapeutic anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123231"}}